Skip to content

Russell E. Poland

3 papers in the library · 194 citations · publishing 1999-2003

Papers

Sort Most recent Most cited

Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users.

The Clinical neuropsychologist November 1, 2003 Carla Back-Madruga, Kyle B. Boone, Linda Chang et al. 57 citations

While neuropsychological studies on 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) users have been emerging, results have been inconsistent, possibly due to methodological issues. The current study examined the performance of 22 recreational MDMA users compared to 28 age, education, and IQ comparable normal control subjects on a comprehensive battery of neuropsychological tests. Results...

Cerebral1H MRS alterations in recreational 3,4-methylenedioxymethamphetamine (MDMA, ?ecstasy?) users

Journal of Magnetic Resonance Imaging October 1, 1999 L. Chang, Thomas Ernst, Charles S. Grob et al. 109 citations

3,4-methylenedioxymethamphetamine (MDMA) is an illicit drug that has been associated with serotonergic axonal degeneration in animals. This study evaluates neurochemical abnormalities in recreational MDMA users. Twenty-two MDMA users and 37 normal subjects were evaluated with magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy ((1)H MRS) in the mid-frontal,...

Cerebral 1H MRS alterations in recreational 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) users

Journal of Magnetic Resonance Imaging October 1, 1999 L. Chang, Thomas Ernst, C.s. Grob et al. 28 citations

3,4-Methylenedioxymethamphetamine (MDMA) is an illicit drug that has been associated with serotonergic axonal degeneration in animals. This study evaluates neurochemical abnormalities in recreational MDMA users. Twenty-two MDMA users and 37 normal subjects were evaluated with magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy (1H MRS) in the mid-frontal, mid-occipital,...